FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024076257> ?p ?o ?g. }

• W2024076257 endingPage "1159" @default.
• W2024076257 startingPage "1151" @default.
• W2024076257 abstract "BACKGROUND The purpose of the current study was to assess the value of routine imaging and liver function tests in detecting metastases from malignant melanoma of the uvea. METHODS Forty-six consecutive patients diagnosed with metastatic uveal melanoma between 1985 and 1996 who had participated in a screening program that included annual liver function tests (LFT), chest X-ray, and abdominal ultrasonography (US) were eligible for this retrospective cohort study. Main outcome measures were the sensitivity of screening tests, presence of symptoms, recurrence free interval, and metastatic burden. RESULTS Metastases were diagnosed in 74% of patients (95% confidence interval [95% CI], 59–86) at screening and in 26% (95% CI, 14–41) when the patient consulted a physician because of symptoms that developed before the next scheduled visit. Of all the patients, 59% (95% CI, 43–73) were asymptomatic, and 80% (95% CI, 66–91) had only hepatic metastases. The median recurrence free interval, greatest dimension of the largest metastasis, and metastatic burden of the two groups did not differ. US was diagnostic in 78% (95% CI, 64–89), at least 1 LFT test was abnormal in 70% of patients (95% CI, 54–82), and a chest X-ray was abnormal in 2% of patients (95% CI, 0–12). LFTs and US did not reveal hepatic metastases in 33% and 4% of patients, respectively. The sensitivity of individual LFTs ranged from 0.27 to 0.67, and their specificity from 0.90 to 0.96, with lactate dehydrogenase being the most sensitive LFT used. CONCLUSIONS The authors believe that annual screening with LFTs and abdominal US will identify 59% of patients while they are still asymptomatic and that semiannual screening will detect >95% of such patients. Chest X-ray has a very low yield and is recommended only at baseline to exclude metastatic disease to the eye and if pulmonary symptoms develop. Cancer 1999;85:1151–9. © 1999 American Cancer Society." @default.
• W2024076257 created "2016-06-24" @default.
• W2024076257 creator A5052598986 @default.
• W2024076257 creator A5076560068 @default.
• W2024076257 creator A5085138114 @default.
• W2024076257 creator A5085670796 @default.
• W2024076257 creator A5089173478 @default.
• W2024076257 date "1999-03-01" @default.
• W2024076257 modified "2023-09-27" @default.
• W2024076257 title "Screening for metastatic malignant melanoma of the uvea revisited" @default.
• W2024076257 cites W1923481401 @default.
• W2024076257 cites W1969624479 @default.
• W2024076257 cites W1973159579 @default.
• W2024076257 cites W1977239706 @default.
• W2024076257 cites W1991933930 @default.
• W2024076257 cites W1998832331 @default.
• W2024076257 cites W2002717293 @default.
• W2024076257 cites W2009173989 @default.
• W2024076257 cites W2013944616 @default.
• W2024076257 cites W2017533041 @default.
• W2024076257 cites W2046723221 @default.
• W2024076257 cites W2049482322 @default.
• W2024076257 cites W2054025824 @default.
• W2024076257 cites W2059734400 @default.
• W2024076257 cites W2060655903 @default.
• W2024076257 cites W2070023785 @default.
• W2024076257 cites W2070512627 @default.
• W2024076257 cites W2081872056 @default.
• W2024076257 cites W2110920908 @default.
• W2024076257 cites W2133193381 @default.
• W2024076257 cites W2163366742 @default.
• W2024076257 cites W2163883625 @default.
• W2024076257 cites W2408680251 @default.
• W2024076257 cites W2409731081 @default.
• W2024076257 cites W4238749013 @default.
• W2024076257 cites W82195015 @default.
• W2024076257 doi "https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1151::aid-cncr20>3.0.co;2-g" @default.
• W2024076257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10091801" @default.
• W2024076257 hasPublicationYear "1999" @default.
• W2024076257 type Work @default.
• W2024076257 sameAs 2024076257 @default.
• W2024076257 citedByCount "148" @default.
• W2024076257 countsByYear W20240762572012 @default.
• W2024076257 countsByYear W20240762572013 @default.
• W2024076257 countsByYear W20240762572014 @default.
• W2024076257 countsByYear W20240762572015 @default.
• W2024076257 countsByYear W20240762572016 @default.
• W2024076257 countsByYear W20240762572017 @default.
• W2024076257 countsByYear W20240762572018 @default.
• W2024076257 countsByYear W20240762572019 @default.
• W2024076257 countsByYear W20240762572020 @default.
• W2024076257 countsByYear W20240762572021 @default.
• W2024076257 countsByYear W20240762572022 @default.
• W2024076257 countsByYear W20240762572023 @default.
• W2024076257 crossrefType "journal-article" @default.
• W2024076257 hasAuthorship W2024076257A5052598986 @default.
• W2024076257 hasAuthorship W2024076257A5076560068 @default.
• W2024076257 hasAuthorship W2024076257A5085138114 @default.
• W2024076257 hasAuthorship W2024076257A5085670796 @default.
• W2024076257 hasAuthorship W2024076257A5089173478 @default.
• W2024076257 hasBestOaLocation W20240762571 @default.
• W2024076257 hasConcept C121608353 @default.
• W2024076257 hasConcept C126322002 @default.
• W2024076257 hasConcept C126838900 @default.
• W2024076257 hasConcept C167135981 @default.
• W2024076257 hasConcept C2776713392 @default.
• W2024076257 hasConcept C2777658100 @default.
• W2024076257 hasConcept C2777910003 @default.
• W2024076257 hasConcept C2779013556 @default.
• W2024076257 hasConcept C44249647 @default.
• W2024076257 hasConcept C502942594 @default.
• W2024076257 hasConcept C512861765 @default.
• W2024076257 hasConcept C71924100 @default.
• W2024076257 hasConcept C90924648 @default.
• W2024076257 hasConceptScore W2024076257C121608353 @default.
• W2024076257 hasConceptScore W2024076257C126322002 @default.
• W2024076257 hasConceptScore W2024076257C126838900 @default.
• W2024076257 hasConceptScore W2024076257C167135981 @default.
• W2024076257 hasConceptScore W2024076257C2776713392 @default.
• W2024076257 hasConceptScore W2024076257C2777658100 @default.
• W2024076257 hasConceptScore W2024076257C2777910003 @default.
• W2024076257 hasConceptScore W2024076257C2779013556 @default.
• W2024076257 hasConceptScore W2024076257C44249647 @default.
• W2024076257 hasConceptScore W2024076257C502942594 @default.
• W2024076257 hasConceptScore W2024076257C512861765 @default.
• W2024076257 hasConceptScore W2024076257C71924100 @default.
• W2024076257 hasConceptScore W2024076257C90924648 @default.
• W2024076257 hasIssue "5" @default.
• W2024076257 hasLocation W20240762571 @default.
• W2024076257 hasLocation W20240762572 @default.
• W2024076257 hasOpenAccess W2024076257 @default.
• W2024076257 hasPrimaryLocation W20240762571 @default.
• W2024076257 hasRelatedWork W1586142365 @default.
• W2024076257 hasRelatedWork W1987035629 @default.
• W2024076257 hasRelatedWork W2071538067 @default.
• W2024076257 hasRelatedWork W2136802909 @default.
• W2024076257 hasRelatedWork W2409084071 @default.
• W2024076257 hasRelatedWork W2426659942 @default.

• next